Lipoxen and SynBio partnered to co-develop six of Lipoxen's drug candidates through proof of concept (POC) in Russia

Lipoxen plc

U.K. / Small-Cap Biopharma (<$1 billion)

$25.5m on 08/05/2011 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

SynBio LLC

Russia / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced